- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Tumor Necrosis Factor Alpha
Total 81 results
-
University of California, San FranciscoEnrolling by invitationStroke | Vasculitis | Aneurysm | Tumor Necrosis Factor-alphaUnited States
-
University Hospital of SplitCompletedInflammatory Response | Surgery | Children, Only | C Reactive Protein | Inguinal Hernia, Indirect | Interleukin-6 | Tumor Necrosis Factor Alpha | White Blood Cell Count, LeukocytesCroatia
-
Fudan UniversityCompletedCerebral Necrosis | Nashopharyngeal Cancer | Nerve Growth FactorChina
-
Gunay ERCompletedSpondyloarthritis | Enthesitis | Anti-Tumor Necrosis Factor Drugs
-
Astellas Pharma Global Development, Inc.WithdrawnSolid Tumors | Epidermal Growth Factor Receptor (EGFR) Mutations
-
National Institute of Neurological Disorders and...CompletedPrimary Brain Tumor | Radiation Necrosis | Glioma Tumor RecurrenceUnited States
-
Second Affiliated Hospital, School of Medicine,...Hangzhou Medical Biotechnology Co., Ltd; CyTIX.IncRecruitingGlioma | Neoplasms | Glioblastoma | Neoplasms, Neuroepithelial | Neuroectodermal Tumors | Neoplasms, Nerve Tissue | Vaccines | Immunologic FactorsChina
-
Esraa Mostafa Ahmed Abdel AalNot yet recruitingLocalization-Related (Focal) (Partial) Idiopathic Epilepsy and Epileptic Syndromes With Seizures of Localized Onset | TRAIL: Tumor Necrosis Factor Related Apoptosis Inducing Ligand MCP-2 | MCP-2: Monocyte Chemo-attractant Protein-2
-
Virginia Commonwealth UniversityCompletedAcute Myocardial InfarctionUnited States
-
NiKang Therapeutics, Inc.RecruitingKidney Cancer | Kidney Neoplasms | Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | Hypoxia | Metastatic Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Renal Cancer | Advanced Renal Cell Carcinoma | Renal Neoplasms | ccRCC | Refractory Renal Cell Carcinoma | Hypoxia Inducible Factor (HIF) | HIF2α... and other conditionsUnited States
-
Dermatologic Cooperative Oncology GroupUnknownTherapy | Adjuvant | Stage III Malignant Melanoma | Interferon AlphaGermany
-
Monteris MedicalCompletedQuality of Life | Progression | Radiation Necrosis | Metastatic Brain TumorsUnited States
-
University of Colorado, DenverGenentech, Inc.TerminatedRadiation NecrosisUnited States
-
The First Affiliated Hospital of Soochow UniversityRecruitingCore Binding Factor Acute Myeloid Leukemia | KIT Mutation-Related TumorsChina
-
Case Comprehensive Cancer CenterThe Cleveland ClinicNot yet recruitingBrain Tumor | Brain Metastases | Brain NecrosisUnited States
-
University of California, San DiegoSan Diego Veterans Healthcare SystemCompletedMyocardial Infarction | Psychosocial FactorsUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingLung Metastases | Tumor NecrosisChina
-
Centre Leon BerardBlueprint Medicines CorporationActive, not recruitingGIST, Malignant | GIST | PDGFR-Alpha D842VFrance
-
North Eastern German Society of Gynaecological...Center for Clinical Trials Philipps University MarburgActive, not recruitingEstrogen Receptor Positive Tumor | Primary Invasive Breast Cancer | Human Epidermal Growth Factor Receptor 2 Negative TumorGermany, Switzerland
-
University of ZurichUniversity Hospital, ZürichCompletedScars | Burn Injury | Soft Tissue Injury | Skin Necrosis | Congenital Giant Nevus | Skin TumorsSwitzerland
-
Jing QiGeneral Hospital of Shenyang Military Region; Zhejiang Chinese Medical University and other collaboratorsUnknownRisk Factor | Ear/*AbnormalitiesChina
-
Memorial Sloan Kettering Cancer CenterCompletedMelanoma | Survivors | Psychological FactorsUnited States
-
AbbVieNo longer availableGlioblastoma or Solid Tumors, Epidermal Growth Factor Receptor (EGFR) Diagnosis
-
Air Force Military Medical University, ChinaNot yet recruitingRisk Factors | Malignant Tumor of Digestive TractChina
-
MedSIRPfizerCompletedBreast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain, Germany, France, United Kingdom, Italy, Slovenia
-
LIB Therapeutics LLCMedpace, Inc.Active, not recruitingCardiovascular Diseases | Hypercholesterolemia | Cardiovascular Risk Factor | Cardiovascular StrokeUnited States, Israel, India
-
AmgenRecruitingSolid TumorsCanada, Korea, Republic of, Australia, Netherlands, United States, Israel, Austria, Spain, United Kingdom, France, Belgium, Italy, Japan, Czechia, Hungary, Poland, Brazil, Argentina, Portugal, Denmark, Greece, Mexico, Switzerland, Rom... and more
-
National Cancer Institute (NCI)Completed
-
Monteris MedicalRecruitingBrain Metastases | Radiation Necrosis | Recurrent Tumor | Recurrent MetastasesUnited States
-
iOMEDICO AGPfizerCompletedBreast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastGermany
-
Peking University People's HospitalPeking University; Northwestern University; University of ChicagoUnknownHistologic Response (Tumor Necrosis Rate) | Objective Response Rate for Neoadjuvant Chemotherapy, ORR | Progression-free Survival, PFS | Overall Survival, OSChina
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Locally Advanced Malignant NeoplasmItaly
-
Dana-Farber Cancer InstituteRecruiting
-
CAS Lamvac Biotech Co., Ltd.Recruiting
-
Zagazig UniversityCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage III MelanomaUnited States
-
National Institute of Allergy and Infectious Diseases...RecruitingMalaria | Sickle Cell Disease | Alpha and Beta Thalassemia | Human PhysiologyUnited States
-
Egyptian Cerebro-Cardio-Vascular AssociationUnknownRisk Factor, Cardiovascular | Ischemia, Myocardial | Ischemia, Cerebral
-
Incyclix BioRecruitingBreast Cancer | Ovarian Cancer | Solid Tumor | Metastatic Cancer | Advanced Cancer | Breast Cancer Metastatic | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | CCNE1 AmplificationUnited States, Australia
-
Northwestern UniversityGlaxoSmithKline; National Comprehensive Cancer Network; Robert H. Lurie Cancer...CompletedRecurrent Islet Cell Carcinoma | Pancreatic Alpha Cell Carcinoma | Pancreatic Beta Islet Cell Carcinoma | Pancreatic Delta Cell Carcinoma | Pancreatic G-cell CarcinomaUnited States
-
European Organisation for Research and Treatment...Hoffmann-La Roche; UNICANCER; Janssen Diagnostics, LLC; SUCCESSCompletedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Circulating Tumor CellsFrance, Germany, Belgium, United Kingdom
-
Ochsner Health SystemBracco CorporateCompletedMyocardial Infarction | Coronary Artery Disease | Cardiac Risk Factors | Normal Healthy Volunteers Without Chronic Medical ConditionsUnited States
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Recruiting
-
Shandong Provincial HospitalRecruitingHematological Tumors Patients With High Risk Factors of Invasive Fungal DiseaseChina
-
University of EdinburghRecruitingAortic Stenosis | Carcinoid Syndrome | Chemotherapy Induced Systolic DysfunctionUnited Kingdom
-
Karen-Lise Garm SpindlerCompletedColorectal Cancer Metastatic | KRAS Gene Mutation | Circulating Tumor DNA | BRAF Gene Mutation | NRAS Gene Mutation | Epidermal Growth Factor Receptor InhibitorDenmark
-
Institut CurieCompletedNon-colorectal Cancer (Esophagus, Stomach, Liver/Bile Ducts, Pancreas, Neuroendocrine Carcinoma) | Colorectal With Associated Risk FactorsFrance
-
University Hospital, LimogesCompletedPrognostic Factors | Survival Analysis | Medullary Carcinoma of ColonFrance
-
Jonsson Comprehensive Cancer CenterNational Center for Advancing Translational Sciences (NCATS)RecruitingGlioblastoma Multiforme | Epidermal Growth Factor Receptor | Glycolytic IndexUnited States